Loading candles…
Innovision Limited, incorporated in 2007, operates in several industries including manpower services, toll plaza management, skill development training, and pharmaceuticals. The company provides manpower services, manages toll plazas, and offers skill development training to clients across India. In the pharmaceutical sector, Innovision engages in manufacturing and marketing pharmaceutical products, including Contract Development and Manufacturing Organization (CDMO) services, domestic branded generics, and international generics. Its operations are supported by a manufacturing infrastructure and a product portfolio that covers various therapeutic areas. The company’s activities are concentrated in the Indian market. There are no publicly listed subsidiaries or notable projects reported, and no information about founders or key management is available.
This page is a live market overview for INNOVISION LIMITED (INNOVISION) on the NSE. As a listed security, INNOVISION LIMITED is tracked in the Services segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for INNOVISION before placing trades on tick2trade.
As of the latest feed, INNOVISION last traded at ₹255.7 on NSE, up ₹1.25 (0.49%) from the previous close of ₹254.45. Today's session range is ₹249.1 – ₹260.5, against a 52-week band of ₹246.2 – ₹470. Traded volume today stands at 31.84K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for INNOVISION in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether INNOVISION is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for INNOVISION LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in INNOVISION. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated INNOVISION option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Unaudited Results - FY26 | To consider and approve the Unaudited financial results(Standalone & Consolidated) for the period ended Jun 30, 2026 | 12 Aug 2026 |
| Results - FY26 | INNOVISION : 28-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 25, 2026 has been re-scheduled. Further, the Company… | 28 May 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 25 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 13 Apr 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.